Literature DB >> 32155982

Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios as Prognostic Markers of Survival in Patients with Head and Neck Tumours-Results of a Retrospective Multicentric Study.

Zsuzsanna Szilasi1, Valéria Jósa2, Zsombor Zrubka3, Tünde Mezei4, Tamás Vass5, Keresztély Merkel5, Frigyes Helfferich1, Zsolt Baranyai6.   

Abstract

BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) may be useful for drawing conclusions about the survival of head and neck squamous cell carcinoma (HNSCC) patients.
METHODS: Clinical data of 156 patients managed for HNSCC at two head and neck surgery centres were analyzed retrospectively. We studied the relationships between survival and PLR as well as NLR.
RESULTS: With regards to 5-year survival, the difference between the two groups with PLR values lower or higher than the threshold was statistically significant (p = 0.004), and we found the same for disease-free survival (p = 0.05), and tumour-specific mortality (p = 0.009). Concerning NLR, the difference in tumour-specific survival was statistically significant (p = 0.006). According to the multivariate analysis, NLR values higher than the threshold indicated an enhanced risk for overall as well as for tumour-specific mortality.
CONCLUSION: In HNSCC patients, a high NLR may be considered as an independent risk factor for 5-year overall survival.

Entities:  

Keywords:  head and neck neoplasms; neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio; survival

Year:  2020        PMID: 32155982     DOI: 10.3390/ijerph17051742

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  7 in total

1.  Systemic immune responses are associated with molecular characteristics of circulating tumor cells in head and neck squamous cell carcinoma.

Authors:  Hiroe Tada; Yurino Nagata; Hideyuki Takahashi; Toshiyuki Matsuyama; Shota Ida; Ikko Mito; Kazuaki Chikamatsu
Journal:  Mol Clin Oncol       Date:  2021-05-26

Review 2.  Pre-treatment neutrophil-to-lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: Meta-analysis and trial sequential analysis.

Authors:  Pierluigi Mariani; Diana Russo; Marco Maisto; Giuseppe Troiano; Vito Carlo Alberto Caponio; Marco Annunziata; Luigi Laino
Journal:  J Oral Pathol Med       Date:  2021-12-09       Impact factor: 3.539

3.  Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes-"Immunological Dose Painting".

Authors:  Camil Ciprian Mireştean; Anda Crişan; Călin Buzea; Roxana Irina Iancu; DragoşPetru Teodor Iancu
Journal:  Medicina (Kaunas)       Date:  2020-12-23       Impact factor: 2.430

4.  The prognostic value of red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in radiotherapy for oropharyngeal cancer.

Authors:  Emilia Staniewska; Bartłomiej Tomasik; Rafał Tarnawski; Mateusz Łaszczych; Marcin Miszczyk
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30

5.  Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.

Authors:  Marta Ruiz-Ranz; Paloma Lequerica-Fernández; Tania Rodríguez-Santamarta; Faustino J Suárez-Sánchez; Rosa M López-Pintor; Juana M García-Pedrero; Juan C de Vicente
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

6.  Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy.

Authors:  Hang-Hang Ni; Xi-Hua Yang; Cheng-Lei Yang; Qian Zhang; Jing-Xuan Xu; Lu-Nan Qi; Bang-De Xiang
Journal:  Biomed Res Int       Date:  2022-07-16       Impact factor: 3.246

7.  Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients.

Authors:  Chengcheng Qian; Renjie Cai; Wenying Zhang; Jiongyi Wang; Xiaohua Hu; Yanjie Zhang; Bin Jiang; Haihua Yuan; Feng Liu
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.